These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 10073832)

  • 1. Effects of dopamine and aminophylline on contrast-induced acute renal failure after coronary angioplasty in patients with preexisting renal insufficiency.
    Abizaid AS; Clark CE; Mintz GS; Dosa S; Popma JJ; Pichard AD; Satler LF; Harvey M; Kent KM; Leon MB
    Am J Cardiol; 1999 Jan; 83(2):260-3, A5. PubMed ID: 10073832
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preventive effects of anisodamine against contrast-induced nephropathy in type 2 diabetics with renal insufficiency undergoing coronary angiography or angioplasty.
    Geng W; Fu XH; Gu XS; Wang YB; Wang XC; Li W; Jiang YF; Hao GZ; Fan WZ; Xue L
    Chin Med J (Engl); 2012 Oct; 125(19):3368-72. PubMed ID: 23044290
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contrast medium-induced nephrotoxicity: pathophysiology and prevention.
    Gerlach AT; Pickworth KK
    Pharmacotherapy; 2000 May; 20(5):540-8. PubMed ID: 10809340
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of benazepril on contrast-induced acute kidney injury for patients with mild to moderate renal insufficiency undergoing percutaneous coronary intervention.
    Li XM; Cong HL; Li TT; He LJ; Zhou YJ
    Chin Med J (Engl); 2011 Jul; 124(14):2101-6. PubMed ID: 21933609
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Contrast nephropathy in cardiac procedures: no advantages with prophylactic use of N-acetylcysteine (NAC)].
    Vallero A; Cesano G; Pozzato M; Garbo R; Minelli M; Quarello F; Formica M
    G Ital Nefrol; 2002; 19(5):529-33. PubMed ID: 12439841
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contrast induced nephropathy in patients with pre-existing renal impairment undergoing coronary angiogram and percutaneous transluminal coronary angioplasty.
    Subedi B; Siddique MA; Zaman SM; Hasan MI; Arzu J; Awal A; Fatema K
    Mymensingh Med J; 2011 Apr; 20(2):270-4. PubMed ID: 21522099
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of single-bolus administration of sodium bicarbonate to prevent contrast-induced nephropathy in patients with mild renal insufficiency undergoing an elective coronary procedure.
    Tamura A; Goto Y; Miyamoto K; Naono S; Kawano Y; Kotoku M; Watanabe T; Kadota J
    Am J Cardiol; 2009 Oct; 104(7):921-5. PubMed ID: 19766757
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical outcomes of contrast-induced nephropathy in patients undergoing percutaneous coronary intervention: a prospective, multicenter, randomized study to analyze the effect of hydration and acetylcysteine.
    Chen SL; Zhang J; Yei F; Zhu Z; Liu Z; Lin S; Chu J; Yan J; Zhang R; Kwan TW
    Int J Cardiol; 2008 Jun; 126(3):407-13. PubMed ID: 17651830
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma neutrophil-gelatinase-associated lipocalin and cystatin C could early diagnose contrast-induced acute kidney injury in patients with renal insufficiency undergoing an elective percutaneous coronary intervention.
    Liu XL; Wang ZJ; Yang Q; Yu M; Shen H; Nie B; Han HY; Gao F; Zhou YJ
    Chin Med J (Engl); 2012 Mar; 125(6):1051-6. PubMed ID: 22613530
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Acute renal failure caused by contrast - as is always the most important prevention].
    Bryniarski L
    Kardiol Pol; 2010 Sep; 68(9):1021-2. PubMed ID: 20859893
    [No Abstract]   [Full Text] [Related]  

  • 11. Coenzyme Q10 combined with trimetazidine in the prevention of contrast-induced nephropathy in patients with coronary heart disease complicated with renal dysfunction undergoing elective cardiac catheterization: a randomized control study and in vivo study.
    Chen F; Liu F; Lu J; Yang X; Xiao B; Jin Y; Zhang J
    Eur J Med Res; 2018 May; 23(1):23. PubMed ID: 29776437
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of hydration with or without n-acetylcysteine on contrast induced nephropathy in patients undergoing coronary angiography and percutaneous coronary intervention.
    Awal A; Ahsan SA; Siddique MA; Banerjee S; Hasan MI; Zaman SM; Arzu J; Subedi B
    Mymensingh Med J; 2011 Apr; 20(2):264-9. PubMed ID: 21522098
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of dopamine in prevention of contrast induced acute renal failure--a randomised study.
    Kapoor A; Sinha N; Sharma RK; Shrivastava S; Radhakrishnan S; Goel PK; Bajaj R
    Int J Cardiol; 1996 Mar; 53(3):233-6. PubMed ID: 8793575
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention of acute renal failure post-contrast imaging in cardiology: a randomized study.
    Alessandri N; Lanzi L; Garante CM; Tersigni F; Sergiacomi R; Petrassi M; Di Matteo A; Tufano F
    Eur Rev Med Pharmacol Sci; 2013 Feb; 17 Suppl 1():13-21. PubMed ID: 23436661
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Simultaneous hemodialysis during coronary angiography fails to prevent radiocontrast-induced nephropathy in chronic renal failure.
    Frank H; Werner D; Lorusso V; Klinghammer L; Daniel WG; Kunzendorf U; Ludwig J
    Clin Nephrol; 2003 Sep; 60(3):176-82. PubMed ID: 14524580
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sodium bicarbonate vs sodium chloride in preventing contrast medium-induced nephropathy.
    Bouzas-Mosquera A; Vázquez-Rodríguez JM; Peteiro J
    JAMA; 2009 Jan; 301(4):378-9; author reply 379-380. PubMed ID: 19176437
    [No Abstract]   [Full Text] [Related]  

  • 17. 20-Hour preprocedural hydration is not superior to 5-hour preprocedural hydration in the prevention of contrast-induced increases in serum creatinine and cystatin C.
    Torigoe K; Tamura A; Watanabe T; Kadota J
    Int J Cardiol; 2013 Sep; 167(5):2200-3. PubMed ID: 22717305
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The contrast media and nephrotoxicity following coronary revascularization by primary angioplasty for acute myocardial infarction study: design and rationale of the CONTRAST-AMI study.
    Bolognese L; Falsini G; Grotti S; Limbruno U; Liistro F; Carrera A; Angioli P; Picchi A; Ducci K; Pierli C
    J Cardiovasc Med (Hagerstown); 2010 Mar; 11(3):199-206. PubMed ID: 19829124
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of effects of isotonic sodium chloride with diltiazem in prevention of contrast-induced nephropathy.
    Beyazal H; Caliskan Z; Utaç C
    Ren Fail; 2014 Apr; 36(3):351-5. PubMed ID: 24341598
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Managing the high-risk patient: experience with fenoldopam, a selective dopamine receptor agonist, in prevention of radiocontrast nephropathy during percutaneous coronary intervention.
    Kini AA; Sharma SK
    Rev Cardiovasc Med; 2001; 2 Suppl 1():S19-25. PubMed ID: 12439364
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.